Higher tumor mutational burden and PD-L1 expression correlate with shorter survival in hematologic malignancies is a research paper published in Therapeutic Advances in Medical Oncology (2024). On theSindex it has a DataRank of 0.339. It has been cited 6 times, with 6 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.292
From this paper's citation signal
Citation Network Contribution
0.0472
From 1 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 6 citers.
national cancer institute
Grant: CA023100
National Institute of Health
Grant: 5U01CA180888-08
National Institute of Health
Grant: 5UG1CA233198-05
MCW NCTN Lead Academic Participating Site
National Institutes of Health
Grant: 3U10CA180888-03S1
SWOG Network Group Operations Center of the NCTN
National Institutes of Health
Grant: 3P30CA023100-25S4
Specialized Cancer Center Support Grant
Joan and Irwin Jacobs Fund
FWCI
1.21
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals